Concepedia

Ziwei Yuan

ZY

6

Publications

156

Citations

6

H-Index

2022

Active since

Affiliations

First Affiliated Hospital of Wenzhou Medical University(Current)

Wenzhou Medical University

Ziwei Yuan is an author at First Affiliated Hospital of Wenzhou Medical University specializing in medicine, tumor biology, and cell signaling.

ORCID

Top concepts

Publications per year

2022–2023

6

Publications

6

Inhibition of STAT3Y705 phosphorylation by Stattic suppresses proliferation and induces mitochondrial-dependent apoptosis in pancreatic cancer cells

Hangcheng Guo, Yanyi Xiao, Ziwei Yuan et al. · Cell Death Discovery · 2022 · 40 citations · Full text

The anthelmintic drug niclosamide induces GSK-β-mediated β-catenin degradation to potentiate gemcitabine activity, reduce immune evasion ability and suppress pancreatic cancer progression

Yangyang Guo, Hengyue Zhu, Yanyi Xiao et al. · Cell Death and Disease · 2022 · 32 citations · Full text

Trans-cinnamaldehyde attenuates renal ischemia/reperfusion injury through suppressing inflammation via JNK/p38 MAPK signaling pathway

Li‐Chen Chen, Jixiang Yuan, Hang Li et al. · International Immunopharmacology · 2023 · 32 citations

, , +12

STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage

Hangcheng Guo, Zujian Hu, Xuejia Yang et al. · International Immunopharmacology · 2023 · 19 citations

, , +9

S100A2 induces epithelial–mesenchymal transition and metastasis in pancreatic cancer by coordinating transforming growth factor β signaling in SMAD4-dependent manner

Qinbo Chen, Hangcheng Guo, Haojie Jiang et al. · Cell Death Discovery · 2023 · 17 citations · Full text

Rows per page

1–5 of 6